Does this company deliver against its own promises? Earnings are a check on the thesis, not a catalyst to chase.
SourcesCompany filings and analyst estimatesFilings and estimates · Latest stored quarter reportedLatest stored report · How we compute this · Not investment advice
Next report
Not yet dated
We hold too few dated reports for this company to estimate its next one.
SURPRISE TRACKING
Just started
scores begin at the next report
Reported EPS, and how the stock reacted
actual EPSprice reaction to the release
Aug '25Sep '26Nov '26
Reaction to the release
−0.3%−3.7%
Estimate-vs-actual scoring began with our first snapshot. Earlier quarters predate our snapshots, so their surprise stays "—". We never backfill an estimate we didn't observe.
The receipt · reported quarters most recent first · each reaction is one session, timed to the release
SCTX reported quarters: EPS, revenue and the price reaction to each release
Report
Act EPS
Act rev
Reaction
Nov 12, 2026press release, after close · 4:05 pm ET
−0.68
$1.6M
−3.7%next session
Sep 2, 2026press release, after close · 4:05 pm ET
−2.62
$1.9M
−0.3%next session
Aug 4, 2025 E
−4.08
$4.9M
—estimated date
E marks a report date we estimated from the fiscal period end, because we found no results release and no usable filing date for that quarter. Those rows show no reaction: a move measured from a day we guessed is not a reaction to the release, and we would rather leave it blank than publish it.
What the street expects next · consensus estimates
Earnings estimate · EPS $
Earnings estimate · EPS $, by forecast horizon
Measure
Dec '26
Mar '27
FY26
FY27
No. of analysts
1
1
2
2
Avg estimate
−0.65
−0.63
−3.68
−2.52
Low estimate
−1.53
−1.48
−5.56
−3.81
High estimate
−0.32
−0.31
−2.52
−1.72
Year-ago EPS
—
—
—
−3.68E
Implied growth
—
—
—
—
Revenue estimate · $
Revenue estimate · $, by forecast horizon
Measure
Dec '26
Mar '27
FY26
FY27
No. of analysts
2
2
3
3
Avg estimate
$5.2M
$2.2M
$10.4M
$6.7M
Low estimate
$3.2M
$1.3M
$7.8M
$5.1M
High estimate
$10.7M
$4.4M
$14.4M
$9.3M
Year-ago revenue
—
—
—
$10.4ME
Implied growth
—
—
—
−35.3%
EPS trend · where the bar has moved
Estimate-history tracking starts with tonight's snapshot. Rows fill in over the next 90 days. We never backfill what we didn't observe.
Estimate movement · the bar itself
Movement tracking starts with tonight's snapshot. Once windows fill, this card shows how far the bar moved into the print, computed from observed snapshots, never reconstructed.
The report date is the day the company released its results: its earnings-release filing with the SEC (an 8-K, or a 6-K for a foreign issuer), checked against the company's own press release. The reaction is the move over the one trading session that first reflects the release: a release before the open runs from the previous close to that day's close, a release after the close from that day's close to the next session's close, and a release during the session or on a day the market is shut from the last close before it to the first close after it. Where we find no release we show the date the quarterly report was filed, mark it, and show no reaction, because a filing can trail the release by days or weeks. For a fiscal fourth quarter with no release found, the date shown is the filing of the annual report, marked as filed, again with no reaction. Where we hold no usable date at all we estimate one from the period end, mark it, and again show no reaction. The bar a quarter is scored against is the consensus we recorded the night before the release, where our record reaches back that far; otherwise it is the last consensus we hold before the date shown, marked unpinned. Surprise = (actual − estimate) ÷ |estimate|. The next report date is the date the company announced in its own release, where it has published one; otherwise it is the data provider's expected date, shown as an expectation. The estimate beside it is the consensus for that quarter, matched by its period end, against the actual for the same quarter a year earlier; where no quarterly consensus is published we show the full-year consensus on its own labelled line against the last full year's actual, never against a single quarter. Where neither the company nor the data provider has a date, we estimate one from the company's own calendar: the day it reported the same quarter a year earlier, moved by 52 weeks, and only when its report dates have moved by a week or less from one year to the next. The estimate is labelled as one and no reminder is sent on it; where the dates have not been steady we show no date and say why. Not investment advice.
Common questions
What were Scribe Therapeutics' latest quarterly earnings?
Scribe Therapeutics reported diluted EPS of −0.68 and revenue of $1.6M on Nov 12, 2026.
How did Scribe Therapeutics' stock move after its last earnings report?
Scribe Therapeutics moved −3.7% in the session after its Nov 12, 2026 report.